| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2882366 | The Annals of Thoracic Surgery | 2007 | 6 Pages |
Abstract
The current investigation expands the experience of safe and effective anticoagulation with bivalirudin during CPB to patients with confirmed or suspected HIT and anti-PF4/H antibodies, including in the setting of impaired renal function.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Andreas MD, Cornelius M. MD, Gabriel MD, Nicholas G. MD, Harry L. CCP, Solomon MD, Roland MD, Edwin MD, Bruce MD, A. Michael MD,